SIGA announced U.S. Government procurement orders of approximately $138 million for oral and IV TPOXX
On Jul. 27, 2023, SIGA Technologies announced that the U.S. Department of Health and Human Services exercised procurement…
NIH released new atlas of human kidney cells to help unlock kidney disease research
On Jul. 19, 2023, the National Institute of Health announced that a nationwide research team had created the…
Perrigo announced U.S. FDA approval for Opill OTC daily oral contraceptive
On Jul. 13, 2023, Perrigo announced that the U.S. Food and Drug Administration had approved Opill, a progestin-only…
18 million doses of first-ever malaria vaccine allocated to 12 African countries for 2023-2025
On Jul. 5, 2023, the IHR National Focal Point of Poland notified WHO of unusual deaths in cats…
U.S. FDA approved BioMarin’s ROCTAVIANï¾™, the first and only gene therapy for adults with severe hemophilia A
On Jun. 29, 2023, BioMarin Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) approved ROCTAVIANï¾™ (valoctocogene…
First U.S.-based Canine Cancer Registry joined international network to help advance canine and human cancer research
On Jun. 26, 2023, Jaguar Health announced that the Take C.H.A.R.G.E. (Canine Health And ReGistry Exchange) had joined…
IHME reported global diabetes cases to soar from 529 million to 1.3 billion by 2050
On Jun. 22, 2023, the Institute for Health Metrics and Evaluation (IHME) reported that more than half a…
Biotechnology | Disease | FDA | Life Science News | Medicine | Therapeutics
U.S. FDA approved first gene therapy for treatment of patients with Duchenne Muscular Dystrophy
On Jun. 22, 2023, the U.S. Food and Drug Administration (FDA) approved Sarepta Therapeutics’s Elevidys, the first gene…
Illumina unveiled AI software to predict disease-causing genetic mutations in patients
On Jun. 1, 2023, Illumina announced the new PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts with unprecedented…
Hundreds of new primate genomes offer window into human health and our past
On Jun. 1, 2023, two international teams announced they have sequenced the genomes of more than 200 nonhuman…
CIRM invested $10 million to build California Cell and Gene Therapy Manufacturing Network
On May 31, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $10 million to five facilities as…
WHO announced simple, easy-to-say labels for SARS-CoV-2 Variants of Interest and Concern
On May 31, 2023, the World Health Organization announced it had assigned simple, easy to say and remember…
Novavax’s Nuvaxovid received positive CHMP opinion for full marketing authorization for prevention of COVID in the EU
On May 26, 2023, Novavax announced that Nuvaxovid (NVX-CoV2373) had been recommended for full Marketing Authorization (MA) for…
843 million people projected to have low back pain by 2050
On May 22, 2023, the Institute for Health Metrics and Evaluation (IHMI) reported low back pain remains the…
FDA approved first topical gene therapy for treatment of wounds in patients with dystrophic epidermolysis bullosa
On May 19, 2023, the U.S. Food and Drug Administration (FDA) approved Krystal Biotech’s Vyjuvek, a herpes-simplex virus…
FDA approved first drug to treat agitation symptoms associated with dementia due to Alzheimer’s disease
On May 11, 2023, the U.S. Food and Drug Administration (FDA) announced the supplemental approval of Otsuka Pharmaceutical…
Scientists released a new human ‘pangenome’ reference
On May 10, 2023, researchers released a new high-quality collection of reference human genome sequences that captures substantially…
NIH researchers identified large genetic changes that contribute to dementia risk
On May 8, 2023, scientists at the National Institutes of Health (NIH) announced that they had identified new…
U.S. FDA approved first Respiratory Syncytial Virus (RSV) vaccine
On May 3, 2023, the U.S. FDA approved GlaxoSmithKline’s Arexvy as the first respiratory syncytial virus (RSV) vaccine…
NIH researchers uncovered new details on rare immune disease
On May 3, 2023, National Institutes of Health (NIH) scientists announced that they had uncovered new details on…
Oregon Health Sciences University dermatologists detected the world’s smallest skin cancer
On May 1, 2023, an Oregon Health Sciences University (OHSU) dermatologist and a multi-disciplinary team confirmed that a…
Study raised concerns SARS-CoV-2 evolution outpaces vaccine-generated antibodies
On Apr. 27, 2023, a NIAID-led Phase 2 trial compared two Pfizer bivalent mRNA COVID-19 boosters found that…
U.S. FDA approved PREVNAR 20, Pfizer’s 20-valent pneumococcal conjugate vaccine for infants and children
On Apr. 27, 2023, Pfizer announced that experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing…
U.S. FDA Approved First Therapeutic Indication for Revance’s DAXXIFY® (DaxibotulinumtoxinA-lanm) for the Treatment of Cervical Dystonia
On Apr. 14, 2023, Revance Therapeutics announced that the U.S. Food and Drug Administration (FDA) had approved the…
Daily statin reduced the risk of cardiovascular disease in people living with HIV, large NIH study found
On Apr. 11, 2023, a National Institutes of Health (NIH) clinical trial was stopped early because a daily…
Highly pathogenic avian influenza confirmed as cause of three California condor mortalities in Arizona
On Apr. 7, 2023, the U.S. National Park Service reported Highly Pathogenic Avian Influenza (HPAI) had been confirmed…
Gene therapy allowed teen to see snowflakes for the first time
On Apr. 5, 2023, researchers at Oregon Health & Science University’s OHSU Casey Eye Institute announced that gene…
Paxlovid reduced risk of long-term health problems, death from COVID-19
On Mar. 23. 2023, researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs…
Quest Diagnostics announced first-of-its-kind post-COVID-19 panels available
On Mar. 21, 2023, Quest Diagnostics announced that it had introduced two innovative Post-COVID-19 panels. These laboratory tests…
CDC acquired 465-acre site in Mace, West Virginia for research facility
On Mar. 21, 2023, the Centers for Disease Control and Prevention announced the acquisition of a site in…